Vasopressor Management in Septic Shock: General Overview and Personalized Approaches
Despite important therapeutic advances, septic shock remains a major challenge associated with 30% to 40% hospital mortality. Vasopressor therapy is a fundamental treatment of septic shock-induced hypotension as it aims at correcting vascular tone depression and improving organ perfusion pressure.
This free webinar provided a general overview of severe septic shock and consequently discussed the benefits of second-line vasopressors and their use in COVID-19 patients.
Dr Jacob JENTZER – Cardiac intensivist and Director of Cardiac Intensive Care Unit Research at Mayo Clinic, Rochester, Minnesota (US).
Prof Arthur R. H. VAN ZANTEN – Chair, Department of Intensive Care and ICU Research in Gelderse Vallei Hospital, Ede (NL); professor of Nutrition and Metabolic Stress by special appointment at Wageningen University & Research (NL).
Prof Dorel SANDESC – Head, A. I.C. clinic, County Clinical Hospital no.1, and Professor, “Victor Babes” University of Medicine and Pharmacy, Timisoara (RO); Vice-President, Romanian Society of Anesthesia and Intensive Care.
Prof Ludhmila HAJJAR – Cardiology Associate Professor, University of São Paulo (BR). Cardio-Oncology Coordinator at the Heart Institute, Hospital das Clínicas, FMUSP. Intensive Care Unit Coordinator at Hospital Paulistano.
Thanks to the support of